ConductScience.org, home

Trial · NCT02636582

Results by group34

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Mean Percent of Nelipepimut-S-specific Cytotoxic T Lymphocyte Response (E75)GM-CSF0.09Inter-Quartile Range 0 to 0.15percent of cytotoxic T lymphocytes
Mean Percent of Nelipepimut-S-specific Cytotoxic T Lymphocyte Response (E75)NPS+GM-CSF0.02Inter-Quartile Range 0 to 0.14percent of cytotoxic T lymphocytes
Intra-tumoral Tumor-infiltrating Lymphocytes (iTILs) Within the Basement MembraneGM-CSF0Inter-Quartile Range -0.5 to 3.0percent of iTILs
Intra-tumoral Tumor-infiltrating Lymphocytes (iTILs) Within the Basement MembraneNPS+GM-CSF0.5Inter-Quartile Range -0.3 to 0.5percent of iTILs
Intra-tumoral Tumor-infiltrating Lymphocytes (iTILs)GM-CSF0Inter-Quartile Range -5 to 0percent of iTILs
Intra-tumoral Tumor-infiltrating Lymphocytes (iTILs)NPS+GM-CSF0Inter-Quartile Range -17.5 to 14.5percent of iTILs
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensGM-CSFHER2 expression - biopsy 1+2Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensNPS+GM-CSFHER2 expression - biopsy 1+3Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensGM-CSFHER2 expression - biopsy 2+2Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensNPS+GM-CSFHER2 expression - biopsy 2+0Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensGM-CSFHER2 expression - biopsy 3+0Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensNPS+GM-CSFHER2 expression - biopsy 3+3Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensGM-CSFHER2 expression - biopsy Normal Breast Tissue0Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensNPS+GM-CSFHER2 expression - biopsy Normal Breast Tissue1Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensGM-CSFHER2 expression - biopsy Missing0Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensNPS+GM-CSFHER2 expression - biopsy Missing3Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensGM-CSFHER2 expression - resection 1+2Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensNPS+GM-CSFHER2 expression - resection 1+1Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensGM-CSFHER2 expression - resection 2+1Participants
Number of Participants With HER2 Expression in Biopsy and Resection SpecimensNPS+GM-CSFHER2 expression - resection 2+1Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02636582/results